| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AN2 Therapeutics, Inc. | Director | Common Stock | 377,542 | $437,948 | $1.16 | 12 Jan 2026 | Indirect |
| AN2 Therapeutics, Inc. | Director | Common Stock | 52,479 | $60,875 | $1.16 | 12 Jan 2026 | Direct |
| AN2 Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 20,400 | 20 Feb 2026 | Direct | ||
| AN2 Therapeutics, Inc. | Director | Stock Optin (Right to Buy) | 19,111 | 22 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ANTX | AN2 Therapeutics, Inc. | 20 Feb 2026 | 1 | $0 | 4 | Director | 23 Feb 2026, 16:21 |
| ANTX | AN2 Therapeutics, Inc. | 12 Jan 2026 | 1 | $0 | 4 | Director | 14 Jan 2026, 17:07 |
| ANTX | AN2 Therapeutics, Inc. | 10 Oct 2025 | 1 | $0 | 4 | Director | 14 Oct 2025, 16:01 |
| ANTX | AN2 Therapeutics, Inc. | 10 Jul 2025 | 1 | $0 | 4 | Director | 11 Jul 2025, 18:23 |
| ANTX | AN2 Therapeutics, Inc. | 22 May 2025 | 1 | $0 | 4 | Director | 23 May 2025, 16:51 |
| ANTX | AN2 Therapeutics, Inc. | 10 Apr 2025 | 1 | $0 | 4 | Director | 11 Apr 2025, 17:03 |
| ANTX | AN2 Therapeutics, Inc. | 19 Dec 2024 | 1 | $0 | 4 | Director | 23 Dec 2024, 18:40 |
| ANTX | AN2 Therapeutics, Inc. | 19 Jun 2024 | 1 | $0 | 4 | Director | 21 Jun 2024, 18:16 |
| ANTX | AN2 Therapeutics, Inc. | 16 Jan 2024 | 2 | -$1,965,000 | 4 | Director | 18 Jan 2024, 18:19 |
| ANTX | AN2 Therapeutics, Inc. | 14 Nov 2023 | 2 | -$29,224 | 4 | Director, 10%+ Owner | 16 Nov 2023, 18:57 |
| ANTX | AN2 Therapeutics, Inc. | 29 Sep 2023 | 4 | -$1,704,513 | 4 | Director, 10%+ Owner | 03 Oct 2023, 19:21 |
| ANTX | AN2 Therapeutics, Inc. | 27 Sep 2023 | 4 | -$150,708 | 4 | Director, 10%+ Owner | 29 Sep 2023, 17:40 |
| ANTX | AN2 Therapeutics, Inc. | 23 Aug 2023 | 2 | -$6,400 | 4 | Director, 10%+ Owner | 15 Sep 2023, 17:40 |
| ANTX | AN2 Therapeutics, Inc. | 23 Aug 2023 | 4 | -$114,484 | 4 | Director, 10%+ Owner | 08 Sep 2023, 16:57 |
| ANTX | AN2 Therapeutics, Inc. | 23 Aug 2023 | 2 | -$6,400 | 4 | Director, 10%+ Owner | 25 Aug 2023, 16:30 |
| ANTX | AN2 Therapeutics, Inc. | 07 Jun 2023 | 1 | $0 | 4 | Director, 10%+ Owner | 09 Jun 2023, 21:04 |
| ANTX | AN2 Therapeutics, Inc. | 06 Jun 2022 | 2 | $0 | 4 | Director, 10%+ Owner | 24 Jun 2022, 17:10 |
| ANTX | AN2 Therapeutics, Inc. | 12 May 2022 | 1 | $0 | 4 | Director | 16 May 2022, 21:19 |
| ANTX | AN2 Therapeutics, Inc. | 29 Mar 2022 | 9 | +$2,499,990 | 4 | Director, 10%+ Owner | 31 Mar 2022, 20:15 |
| ANTX | AN2 Therapeutics, Inc. | 24 Mar 2022 | 0 | $0 | 3 | Director | 24 Mar 2022, 21:24 |